<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Forty-seven patients with cerebral <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> type 2 were included in the study </plain></SENT>
<SENT sid="1" pm="."><plain>To maintain the target values of glycemia on the level 7.8-10.2 mmol/l, patients of the main group received the continuous intravenous infusion of insulin and patients of the control group received frequent (every 3h) subcutaneous injections of insulin during the first 24 h after the <z:hpo ids='HP_0011009'>acute</z:hpo> cerebral blood flow disturbance </plain></SENT>
<SENT sid="2" pm="."><plain>The results obtained have shown that continuous intravenous insulin infusion reduces the risk of <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo>, accelerates positive neurologic dynamics, reduces terms of hospitalization and decreases mortality in patients with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> type 2 </plain></SENT>
</text></document>